Andres Maldonado HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
48
Avg Return
Past Year
Past Year
31%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $11 |
14%
upside
| 1 | +129% |
0
%
| 13 Jan ‘26 7 days ago |
|
|
|
Neutral
Maintained
| $10 |
28%
downside
| 1 | – |
–
| 22 Dec ‘25 29 days ago |
|
|
|
Buy
Maintained
| $4 |
628%
upside
| 1 | -32% |
0
%
| 19 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $60 |
64%
upside
| 2 | +89% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $23 |
359%
upside
| 2 | +9.6% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $25 |
146%
upside
| 1 | -2.1% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $7 |
519%
upside
| 1 | -8.8% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $40 |
95%
upside
| 1 | +21% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $40 |
381%
upside
| 1 | +22% |
0
%
| 20 Oct ‘25 3 months ago |
|